Valuation: Philogen S.p.A.

Market Cap 847M 935M 784M 707M 1.33B 88.15B 1.38B 9.41B 3.73B 47.09B 3.51B 3.43B 149B P/E 2026 *
-27x
P/E 2027 * -42.2x
Enterprise Value 634M 700M 587M 529M 998M 66B 1.03B 7.05B 2.79B 35.26B 2.63B 2.57B 112B EV / Sales 2026 *
7.99x
EV / Sales 2027 * 14.3x
Free-Float
26.38%
Yield 2026 *
3.42%
Yield 2027 * 1.66%
1 day-1.64%
1 week-0.47%
Current month+1.69%
1 month-0.71%
3 months-11.92%
6 months-4.54%
Current year-9.66%
1 week 20.65
Extreme 20.65
21.5
1 month 20.35
Extreme 20.35
21.95
Current year 19.56
Extreme 19.56
26
1 year 19.56
Extreme 19.56
26
3 years 16.3
Extreme 16.3
27.8
5 years 13
Extreme 13
27.8
10 years 12.6
Extreme 12.6
27.8
Manager TitleAgeSince
Chief Executive Officer 63 2020-10-04
Chief Executive Officer 63 1995-12-31
Director of Finance/CFO 55 -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 57 1995-12-31
Director/Board Member 63 1995-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
2/5/26 Sell

Director

800 0.0027%
5/28/24 Buy

Director

10,000 0.0342%
1/25/22 Buy

Director

3,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%-0.47%-9.66%+15.34% 935M
-2.69%-0.48%+53.97%+70.99% 66.33B
-0.92%+7.67%+14.26%+90.92% 60.62B
0.00%+0.39%+20.52%+98.45% 55.5B
+0.14%+2.35%+13.86%+106.64% 47.58B
-2.21%-2.47%+20.18%+32.24% 43.69B
-2.30%-10.40%+154.30%+725.54% 37.27B
+2.15%+1.42%+15.17%+56.49% 36.57B
-2.32%-2.24%+75.52%+52.70% 32.22B
+2.62%+5.90%-37.29%+393.72% 26.58B
Average -0.72%-0.00%+32.08%+164.30% 41B
Weighted average by Cap. -0.83%+0.20%+36.49%+155.78%

Financials

2026 *2027 *
Net sales 79.41M 87.63M 73.45M 66.27M 125M 8.26B 129M 882M 350M 4.41B 329M 322M 14.01B 42.6M 47.01M 39.4M 35.55M 66.99M 4.43B 69.35M 473M 188M 2.37B 176M 173M 7.52B
Net income -32M -35.31M -29.6M -26.7M -50.33M -3.33B -52.1M -356M -141M -1.78B -133M -130M -5.65B -20.03M -22.11M -18.53M -16.72M -31.51M -2.08B -32.62M -223M -88.27M -1.11B -82.97M -81.21M -3.53B
Net Debt -213M -235M -197M -178M -335M -22.15B -347M -2.37B -938M -11.83B -882M -863M -37.56B -238M -263M -220M -199M -374M -24.77B -388M -2.65B -1.05B -13.23B -986M -965M -42B
Projected Income Statement - Annual - Philogen S.p.A.
Logo Philogen S.p.A.
Philogen SpA is an Italy-based company operating in the biotechnology sector. The Company develops products and technologies for the diagnosis and therapy of serious human diseases. It focuses mainly on discovering and developing targeted anti-cancer drugs, using high-affinity ligands for tumor markers. These ligands are identified through Antibody Phage Display Libraries and DNA-Encoded Chemical Libraries technologies. The Company’s products primarily address applications in the oncology field, the targeting approach is also potentially applicable to other diseases, such as certain chronic inflammatory diseases. It has four anti-cancer antibody derivatives in clinical studies, one of which has completed a Phase III trial. The Company is active in the Discovery Unit through its subsidiary Philochem AG.
Employees
230
Date Price Change Volume
26-11-13 €21.05 -1.64% 10,036
26-11-12 €21.40 +1.90% 25,419
26-11-11 €21.00 +1.45% 9,737
26-11-10 €20.70 -2.59% 16,167
26-11-09 €21.25 +0.47% 11,884
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Philogen S.p.A.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
21.05EUR
Average target price
28.33EUR
Spread / Average Target
+34.60%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Philogen S.p.A.
  1. Stock Market
  2. Stocks
  3. PHIL Stock